UnitedHealth's healthcare services arm, Optum, and DaVita Medical Group received a second request from the Federal Trade Commission for more information on their proposed $4.9 billion deal, according to a recent Securities and Exchange Commission filing.
The request will extend a waiting period until 30 days after Optum and DaVita answer the second request, unless the parties chose to do so voluntarily. DaVita and Optum said they "have been working, and will continue to work, diligently and cooperatively with the FTC in connection with the FTC's review."
Optum extended its $4.9 billion offer to DaVita in December 2017. If approved and completed, the deal will add nearly 300 medical clinics to Optum's network.
DaVita still expects the deal to close in 2018.